'The ship has turned.' JPMorgan upgrades iconic U.K. retailer Marks & Spencer
By Steve Goldstein
Marks & Spencer, the storied U.K. retailer, saw an upgrade to overweight at JPMorgan, as the bank said it's the retailer demonstrating the biggest positive inflection out of the pandemic.
While rival Next has taken the most market share since the pandemic, M&S market share gains are the highest year-over-year, said the bank.
"It is the only retailer within the six players that we consider below where a change in direction of market share trend has been witnessed and gains have continued into 2024," said analysts led by Georgina Johanan. "We prefer to own the retailer where share gains are highest, expectations are lowest, and valuation least demanding."
Marks & Spencer shares (UK:MKS) rose 2% in early trade.
The analysts have neutral ratings on Next (UK:NXT) and Associated British Foods (UK:ABF), which owns Primark. Next shares inched higher while ABF stock fell 1%.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-11-24 0410ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters